EGFR and glioblastoma: The therapeutic potential of the benzoporphyrin derivative verteporfin, an inhibitor of TAZ/YAP-TEAD complex, was recently examined and it was shown that verteporfin suppressed expression of TAZ/YAP transcriptional targets and induced apoptosis of EGFR-amplified/mutant GBM cells [156].